Philly.com: Cephalon being investigated again

Bill Marth, President & Chief Executive Officer Americas for Teva Pharmaceutical Industries, Ltd., said Tuesday at the groundbreaking for a new facility in the Philadelphia neighborhood of Bustleton that Cephalon's latest troubles won't impede Teva's acquisition of Cephalon. Marth [who is a USciences board member] said Teva still expects that deal to close in October of this year.

Read more: http://www.philly.com/philly/blogs/phillypharma/Cephalon-being-investigated-again.html

Posted by University of the Sciences

Post a comment.

If you have a TypeKey or TypePad account, please Sign In.

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

© 2011 University of the Sciences in Philadelphia • 600 South 43rd Street • Philadelphia, PA 19104 • 215.596.8800